D. Ross Camidge

机构：University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, University of Colorado Denver · ORCID：0000-0003-3430-3213

发表论文 993 篇 · 总被引 64976 次 · h-index 113

代表论文

• Durvalumab Alone or Combined With Novel Agents for Unresectable Stage III Non–Small Cell Lung Cancer (2025 · JAMA Network Open · 被引 26)
• Alectinib versus crizotinib in previously untreated ALK-positive advanced non-small cell lung cancer: final overall survival analysis of the phase III ALEX study (2025 · Annals of Oncology · 被引 20)
• Integrated molecular and clinical characterization of pulmonary large cell neuroendocrine carcinoma (2025 · Nature Communications · 被引 14)
• Osimertinib vs. Afatinib in 1L therapy of atypical EGFR-mutated metastatic non-small cell lung cancer (mNSCLC): A multi-institution, real-world survival analysis (2025 · Lung Cancer · 被引 6)
• A phase 1b study of cofetuzumab pelidotin monotherapy in patients with PTK7-expressing recurrent non-small cell lung cancer (2025 · Lung Cancer · 被引 6)
• PL02.15 Pivotal ARROS-1 Efficacy and Safety Data: Zidesamtinib in TKI Pre-treated Patients with Advanced/Metastatic ROS1+ NSCLC (2025 · Journal of Thoracic Oncology · 被引 5)